首页 › 肾癌(肾细胞癌) › 加利福尼亚州 › San Francisco
San Francisco CA 肾癌(肾细胞癌)临床试验
11项针对 肾癌(肾细胞癌)的研究正在 San Francisco及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
招募中1/2 期
- UCSF Medical Center at Mission Bay ( Site 5008), San Francisco
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
招募中1/2 期
- University of California San Francisco, San Francisco
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
招募中2 期
- UCSF Medical Center-Mission Bay, San Francisco
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
招募中3 期
- California Pacific Medical Center-Pacific Campus, San Francisco
Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
招募中2 期
- University of California, San Francisco, San Francisco
Imaging of Solid Tumors Using 18F-TRX
招募中1 期
- University of California, San Francisco, San Francisco
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
招募中
- Zuckerberg San Francisco General, San Francisco
- Kaiser Foundation Research Institute, San Francisco
- University of San Francisco, San Francisco
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
招募中1/2 期
- University of California San Francisco (UCSF), San Francisco
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
招募中3 期
- California Pacific Medical Center-Pacific Campus, San Francisco
A Multicenter Cancer Biospecimen Collection Study
招募中观察性研究
- Curebase, San Francisco
A Study of IBI363 in Subjects with Advanced Solid Malignancies
招募中2 期
- University of California, San Francisco (UCSF), San Francisco
其他城市的 肾癌(肾细胞癌)试验
- Houston, TX35 项研究
- New York City, NY27 项研究
- Dallas, TX23 项研究
- Nashville, TN23 项研究
- St. Louis, MO23 项研究
- Los Angeles, CA20 项研究
- Boston, MA16 项研究
- Baldwin Park, CA16 项研究
- Pittsburgh, PA15 项研究
- Philadelphia, PA15 项研究
- Queens, NY15 项研究
- Jacksonville, FL14 项研究
San Francisco的其他研究
- 前列腺癌45 项研究
- 乳腺癌43 项研究
- 非小细胞肺癌36 项研究
- 癌症(所有类型)35 项研究
- 心力衰竭29 项研究
- 转移性癌症28 项研究
- 肺癌22 项研究
- 黑色素瘤22 项研究
- 胰腺癌20 项研究
- 卵巢癌19 项研究
- 结直肠癌18 项研究
- 心血管疾病18 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月6日。每项研究自行设定入选标准,由研究团队决定谁能参与。